AZD8421

AZD8421 is a potent, selective CDK2 inhibitor (IC50 = 9 nM) that suppresses Rb phosphorylation and cell proliferation. It demonstrates significant antitumor activity in breast and ovarian cancer models, both alone and combined with CDK4/6 inhibitors, supporting its use in oncology research.